Analyst Reco. Privia Health Group, Inc.

Equities

PRVA

US74276R1023

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
18.26 ^USD	+1.50%		+1.00%	-20.71%

Apr. 22	Citigroup Starts Privia Health Group With Buy Rating, $25 Price Target	MT
Mar. 19	Canaccord Genuity Adjusts Privia Health Group Price Target to $37 From $41, Maintains Buy Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Citigroup Starts Privia Health Group With Buy Rating, $25 Price Target	Apr. 22	MT
Canaccord Genuity Adjusts Privia Health Group Price Target to $37 From $41, Maintains Buy Rating	Mar. 19	MT
JPMorgan Cuts Price Target on Privia Health to $30 From $38, Maintains Overweight Rating	Mar. 06	MT
Barclays Starts Coverage on Privia Health With Equalweight Rating, $22 Price Target	Mar. 06	MT
UBS Adjusts Privia Health Group Price Target to $29 From $31, Maintains Buy Rating	Mar. 01	MT
TD Cowen Adjusts Price Target on Privia Health to $26 From $30, Maintains Outperform Rating	Mar. 01	MT
Truist Securities Cuts Price Target on Privia Health Group to $28 From $32, Maintains Buy Rating	Feb. 29	MT
RBC Trims Price Target on Privia Health Group to $28 From $32, Keeps Outperform Rating	Feb. 16	MT
JMP Securities Initiates Privia Health Group With Market Outperform Rating, Price Target is $27	Dec. 06	MT
JPMorgan Cuts Privia Health Group's Price Target to $38 From $43, Keeps Overweight Rating	Nov. 17	MT
UBS Trims Privia Health Group Price Target to $31 From $32, Maintains Buy Rating	Nov. 07	MT
RBC Cuts Price Target on Privia Health Group to $32 From $36, Keeps Outperform Rating	Nov. 06	MT
UBS Adjusts Privia Health Price Target to $32 From $35, Maintains Buy Rating	23-08-18	MT
TD Cowen Adjusts Price Target on Privia Health to $35 From $44, Maintains Outperform Rating	23-08-15	MT
Evercore ISI Group Initiates Privia Health Group at Outperform With $34 Price Target	23-06-13	MT
UBS Adjusts Privia Health Price Target to $35 From $30, Maintains Buy Rating	23-05-09	MT
Stephens Initiates Privia Health Group at Overweight With $33 Price Target	23-04-12	MT
Privia Health Group Initiated at Outperform by RBC, Price Target Set at $36; Firm Highlights Differentiation, Market Size	23-03-10	MT
Goldman Sachs Initiates Coverage on Privia Health Group With Buy Rating, $32 Price Target	23-02-03	MT
Stifel Starts Privia Health Group at Buy With $28 Price Target	22-12-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Privia Health Group, Inc.

Equities

PRVA

US74276R1023

Analyst Reco.

Filters